HPE Europe 2020: What Are the Life Science Transaction Trends in the Wake of the Sanitary Crisis?

Overview



Fresh from leading at the forefront of the pandemic, the life sciences industry now comes together and reacts to the uncertainty of the post-crisis market. Though the impact will be transient in the long-term, the full effects of the crisis should be contrasted across different segments of the life sciences sector. There will be strong opportunities post the crisis for companies with solid foundations.

The life sciences sector has moved from an in-house model to an increased reliance on partnering for R&D, manufacturing and logistics services, as well as for product acquisitions. In our latest webinar, we will cover:

  • What specific deal trends and investment opportunities are emerging from the crisis?
  • How is deal making impacted?
  • What does greater investment into research and development mean for the next generation of scientific discovery?

To learn more about this series click here.

Speakers


MODERATOR

  • Emmanuelle Trombe, Partner, McDermott Will & Emery

Dig Deeper

Paris, France / McDermott Event / October 18, 2022

European Healthcare & Life Sciences Forum

London, United Kingdom / McDermott Event / September 29, 2022

HPE Europe 2022

Arlington, VA / National Vaccine Law Conference / September 15-16, 2022

National Vaccine Law Conference

Washington, DC / 340B Coalition Summer Conference / August 1-3, 2022

340B Coalition Summer Conference

Nashville, TN / HealthTrust / July 25-26, 2022

HealthTrust University Conference

Chicago, IL / McDermott Event / June 28, 2022

McDermott's Annual AHLA Meeting Reception 2022

Get In Touch